Amgen Inc.
MX ˙ BMV ˙ NL0000888691
SecurityMX:AMGN / Amgen Inc.
InstitutionCypress Capital, LLC
Latest Disclosed Ownership8,363 shares
Latest Disclosed Value $ 2,942,522
Cypress Capital, LLC reports 1.15% decrease in ownership of AMGN / Amgen Inc.

On April 28, 2026 - Cypress Capital, LLC filed a 13F-HR form disclosing ownership of 8,363 shares of Amgen Inc. (MX:AMGN) valued at $2,942,522 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 6, 2026 disclosing 8,460 shares of Amgen Inc.. This represents a change in shares of -1.15% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-28 2026-03-31 13F AMGEN COM 031162100 8,363 -97 -1.15 2,943 6.25 0.8372
2026-02-06 2025-12-31 13F AMGEN COM 031162100 8,460 125 1.50 2,769 17.73 0.7753
2025-10-23 2025-09-30 13F AMGEN COM 031162100 8,335 -270 -3.14 2,352 -2.08 0.6729
2025-08-07 2025-06-30 13F AMGEN COM 031162100 8,605 -4 -0.05 2,403 -10.44 0.6978
2025-04-25 2025-03-31 13F AMGEN COM 031162100 8,609 170 2.01 2,682 21.96 0.7732
2025-02-03 2024-12-31 13F AMGEN COM 031162100 8,439 301 3.70 2,200 -16.13 0.6290
2024-11-12 2024-09-30 13F AMGEN COM 031162100 8,138 -114 -1.38 2,622 1.71 0.6764
2024-08-22 2024-06-30 13F AMGEN COM 031162100 8,252 56 0.68 2,578 10.64 0.7700
2024-10-29 2024-03-31 13F AMGEN COM 031162100 8,196 -216 -2.57 2,330 -3.80 0.6373
2024-02-05 2023-12-31 13F AMGEN COM 031162100 8,412 87 1.05 2,423 8.27 0.7355
2023-11-09 2023-09-30 13F AMGEN COM 031162100 8,325 8,325 2,237 0.6865
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.